Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor‐associated myocarditis: A systematic review and meta‐analysis
Cancer Innovation · 2024-06 · 3 (3)
DOI: 10.1002/cai2.109 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Cancer Innovation, online erschienen am 15.04.2024. Verfasst von Wenhua Song und 6 weiteren Autor:innen. Beteiligte Einrichtung: Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology Second Hospit…. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Immune checkpoint inhibitors (ICI) are increasingly used in the first‐line treatment of malignant tumors. There is increasing recognition of their cardiotoxicity and, in particular, their potential to lead to myocarditis. Cardiovascular magnetic resonance (CMR) can quantify pathological changes, such as myocardial edema and fibrosis. The purpose of this systematic review and meta‐analysis was to examine the evidence for the roles of CMR in predicting prognosis in ICI‐associated myocarditis.
Methods
PubMed, Cochrane Library, and Web of Science databases were searched until October 2023 for published works investigating the relationship between CMR parameters and adverse events in patients with ICI‐associated myocarditis. The analysis included studies reporting the incidence of late gadolinium enhancement (LGE), T1 values, T2 values, and CMR‐derived left ventricular ejection fraction (LVEF). Odds ratios (OR) and weighted mean differences (WMD) were combined for binary and continuous data, respectively. Newcastle‐Ottawa Scale was used to assess the methodological quality of the included studies.
Results
Five cohort studies were included (average age 65–68 years; 25.4% female). Of these, four studies were included in the meta‐analysis of LGE‐related findings. Patients with major adverse cardiovascular events (MACE) had a higher incidence of LGE compared with patients without MACE (OR = 4.18, 95% CI: 1.72–10.19, p = 0.002). A meta‐analysis, incorporating data from two studies, showed that patients who developed MACE exhibited significantly higher T1 value (WMD = 36.16 ms, 95% CI: 21.43–50.89, p < 0.001) and lower LVEF (WMD = − 8.00%, 95% CI: −13.60 to −2.40, p = 0.005). Notably, T2 value (WMD = −0.23 ms, 95% CI: −1.86 to −1.39, p = 0.779) was not associated with MACE in patients with ICI‐related myocarditis.
Conclusions
LGE, T1 value, and LVEF measured by CMR imaging have potential prognostic value for long‐term adverse events in patients with ICI‐related myocarditis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Department of Cardiology, Tianjin Institute of Cardiology Second Hospital of Tianjin Medical University Tianjin China.
- Department of Radiology Second Hospital of Tianjin Medical University Tianjin China.
- School of Nursing and Health Studies Hong Kong Metropolitan University Hong Kong China.
- Cardiac Electrophysiology Unit Cardiovascular Analytics Group, PowerHealth Limited Hong Kong China.
ORCID-Profile: Tong Liu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Song, W., Zhang, N., Lv, T., Zhao, Y., Li, G., Tse, G., & Liu, T. (2024). Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor‐associated myocarditis: A systematic review and meta‐analysis. Cancer Innovation, 3(3). https://doi.org/10.1002/cai2.109
Vancouver
Song W, Zhang N, Lv T, Zhao Y, Li G, Tse G, et al. Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor‐associated myocarditis: A systematic review and meta‐analysis. Cancer Innovation. 2024;3(3). doi:10.1002/cai2.109
BibTeX
@article{Song2024,
author = {Song, Wenhua and Zhang, Nan and Lv, Tonglian and Zhao, Yang and Li, Guangping and Tse, Gary and Liu, Tong},
title = {Prognostic value of cardiovascular magnetic resonance in immune checkpoint inhibitor‐associated myocarditis: A systematic review and meta‐analysis},
journal = {Cancer Innovation},
year = {2024},
volume = {3},
number = {3},
doi = {10.1002/cai2.109}
}
EUVIMED